United States Neonatal Point of Care Testing Market sees strong growth CAGR of 11.5%, Market Growth Outlook: Size, Trends & Future Forecast to 2031 | Key Players:- PerkinElmer, Inc., Trivitron Healthcare, Natus Medical Incorporated, GE Healthcare

The Neonatal Point Of Care Testing Market reached US$ 971 million in 2023 and is expected to reach US$ 2,273 million by 2031, growing at a CAGR of 11.5% during the forecast period 2024-2031.

DataM Intelligence unveils its latest report on the "Neonatal Point Of Care Testing Market size 2026," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/neonatal-point-of-care-testing-market?pratik

United States: Key Industry Developments (2025)

✅ July 2025: Abbott Laboratories launched a next‐generation neonatal POCT device capable of rapid bedside testing for bilirubin, blood gases, and glucose levels, improving timely diagnosis and clinical decision‐making in NICUs.

✅ June 2025: Roche Diagnostics expanded its cobas b 101 system for neonatal care with enhanced multiplexed biomarker detection capabilities, reducing turnaround time for critical lab results and supporting faster treatment interventions.

✅ May 2025: Nova Biomedical introduced wireless‐connected POCT devices for neonatal intensive care, enabling real‐time monitoring and seamless integration with hospital EMR systems for enhanced patient management workflows.

Asia Pacific / Japan: Key Industry Developments (2025)

✅ July 2025: Fujifilm Wako Pure Chemical Corporation launched a compact neonatal POCT analyzer for glucose and bilirubin measurement in Japan, designed for small clinics and NICU units to support early intervention.

✅ June 2025: Sysmex Corporation developed automated blood cell counting POCT systems optimized for neonatal samples, minimizing sample volume requirements and improving accuracy for critical newborn assessments.

✅ May 2025: Terumo Corporation partnered with Japanese hospitals to deploy integrated POCT platforms for neonatal sepsis markers, enabling real‐time monitoring and early intervention strategies in at‐risk infants.

Neonatal Point Of Care Testing Market Dynamics
The Rising Prevalence of Genetic Diseases in Neonates

The rising prevalence of genetic diseases among the newly born is expected to increase demand for the point of care testing devices and tests. The increasing diseases will create an awareness for the use of tests and devices to study the progression of the diseases. Increasing individuals wit ghenetic diseases will often drive the market growth.

For instance, according to a study by the Emory University in 2023, it is estimated that classic galactosemia is an inborn error of metabolism that impacts about 1:50,000 babies born each year in the US and many other countries.

Additionally, according to the report by the Children's Hospital of Philadelphia, it is statedd that approximately 2,500 babies are born with the disorder each year in the United States.

By providing timely, reliable, yet affordable and easy-to-use on-site diagnostic tests, and enabling neonatal health monitoring at home even in rural or remote areas, neonatal point-of-care testing (NPOCT) can be vital in reducing neonatal morbidity and mortality rates. The development of point of care testing devices and assays helps the individuals to monitor the diseases and helps to take precautions.

Lack of Proper Knowledge about Point of Care Testing

Point-of-care testing often involves the use of cutting-edge technology and procedures that not all healthcare professionals are familiar with, particularly those who operate in less specialized or resource-constrained environments. A lack of knowledge about the capabilities and operation of these tests may cause skepticism or hesitancy when implementing them.

Key Players:-
PerkinElmer, Inc. | Trivitron Healthcare | Natus Medical Incorporated | GE Healthcare | Siemens Healthineers | QIAGEN Inc.| Bilimetrix S.r.l | Owen Mumford | Radiometer Medical ApS | Meridian Bioscience

📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=neonatal-point-of-care-testing-market?pratik

Key Growth Drivers
◾ Surge in preterm births raises need for immediate bedside testing to detect disorders early.
◾ Demand for quick results cuts lab delays, enabling faster neonatal interventions.
◾ Heightened awareness of neonatal health risks boosts adoption of portable devices.
◾ Portable testing expands access in remote areas via remote patient monitoring.
◾ Investments in advanced diagnostics like biosensors drive personalized neonatal care.

Regional Highlights:-

North America commands the largest share of the Neonatal Point Of Care Testing Market, estimated at around 45% in recent assessments, driven by advanced NICU infrastructure, high preterm birth rates, substantial R&D investments, and favorable reimbursement policies in the US and Canada.

Europe follows as the second-largest region, benefiting from stringent medical device regulations, rising adoption in countries like Germany, France, and the UK, and growing focus on early neonatal diagnostics, though exact shares vary by report amid steady market expansion.

Asia Pacific ranks third in market share, yet exhibits the fastest growth potential with high CAGRs in nations such as China, India, and Japan, fueled by increasing healthcare spending, government initiatives for newborn care, and expanding neonatal populations.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/neonatal-point-of-care-testing-market?pratik

Market Segmentation-

By Product: Instruments vs Assays
Instruments lead with 62.7% market share in 2024, driven by demand for rapid, on-site analyzers like blood gas and glucose monitors essential for immediate neonatal diagnostics in NICUs.
Assays capture the remaining 37.3% share, valued for their consumable nature in tests for biomarkers like C-reactive protein and bilirubin, with steady growth from point-of-care kits.

By End-User: Hospitals vs Others
Hospitals dominate with 58.4% share in 2025, as central hubs for critical neonatal care equipped with advanced POC devices for real-time monitoring.
Diagnostic centers hold 21.6%, focusing on outpatient testing for preterm screenings.
Maternity & specialty clinics account for 14.2%, rising with portable tech for bedside use, while others (like home care) take 5.8% amid telehealth trends.

FAQ'S

Q1: What is Neonatal Point of Care Testing (POCT) and why is it important?
A1: Neonatal Point of Care Testing refers to rapid diagnostic tests performed at or near the site of a newborn's care, such as hospitals or clinics. It enables early detection of critical conditions like infections, jaundice, or metabolic disorders, ensuring timely interventions and improved neonatal outcomes.

Q2: What factors are driving the growth of the Neonatal Point of Care Testing Market?
A2: Market growth is driven by increasing neonatal health awareness, rising incidences of preterm births and genetic disorders, technological advancements in portable diagnostic devices, and the demand for faster, accurate testing to improve newborn care in both developed and emerging regions.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?pratik

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele

This release was published on openPR.